PTPA and pancreatic neoplasm: In the cell proliferation assay, the viability of both pancreatic cancer cell lines was significantly decreased by the addition of PP2A inhibitor to FUT‐175 (PANC‐1, P<.0001; MIAPaCa‐2, P<.0001, Figure 4B).